Guardian Pharmacy Services, Inc.
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.53% | 19.54% | 17.42% | 16.86% | 14.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.53% | 19.54% | 17.42% | 16.86% | 14.66% |
| Cost of Revenue | 18.97% | 19.55% | 17.44% | 17.45% | 15.32% |
| Gross Profit | 16.72% | 19.52% | 17.31% | 14.49% | 12.09% |
| SG&A Expenses | 95.67% | 112.00% | 107.43% | 66.57% | 19.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.67% | 32.79% | 30.63% | 25.69% | 15.90% |
| Operating Income | -188.90% | -175.00% | -184.09% | -187.69% | -3.06% |
| Income Before Tax | -472.74% | -295.76% | -311.79% | -311.49% | -71.95% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -543.80% | -318.86% | -323.87% | -311.94% | -71.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 61.25% | 16.63% | -17.63% | -26.16% | -13.79% |
| Net Income | -11,393.82% | -511.07% | -521.29% | -526.70% | -98.44% |
| EBIT | -188.90% | -175.00% | -184.09% | -187.69% | -3.06% |
| EBITDA | -142.20% | -135.67% | -141.61% | -128.76% | -0.41% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -822.56% | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -829.91% | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 304.42% | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 308.85% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.00% | -1.18% | -1.22% | -1.35% | 95.92% |